SN

Sunil Narnoli

Active Director Director DIN 07127429
DIN 07127429 First appointment Mar 2015 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Mar 2015
Shareholding value Locked Premium profile

About Sunil Narnoli

Sunil Narnoli has 11 years in corporate governance. Holds Director role. Currently with 1 company, including Aps Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 07127429
Primary Designation Director
First Appointment 13 Mar 2015
Oldest Company Age 20 yrs

Current companies

Company Designation Appointment Founded Status
Aps Biotech Private Limited U24230UR2005PTC007161
Director 13 Mar 2015 2005 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aps Biotech Private Limited
Premium access

Shareholding and investment profile for Sunil Narnoli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Narnoli

Sunil Narnoli has 11 years in corporate governance. Holds Director role. Currently with 1 company, including Aps Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Sunil Narnoli is associated with 1 company as Director.

Sunil Narnoli has expertise in Technology.

Sunil Narnoli has 11 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available